Clinical Trials Directory

Trials / Unknown

UnknownNCT05339919

Relationship Between Liver Cancer and Sarcopenia

The Effect of Sarcopenia on Hepatocellular Carcinoma After Hepatectomy

Status
Unknown
Phase
Study type
Observational
Enrollment
1,200 (estimated)
Sponsor
First Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

By tracking the short-term and long-term results of patients after hepatectomy, the difference of short-term results between patients with sarcopenia and patients without sarcopenia was analyzed, and the correlation between sarcopenia and short-term and long-term results of patients after hepatectomy was explored, so as to improve people's awareness of sarcopenia and pay attention to its prevention and treatment.

Detailed description

All implementation details are based on the newest EWGSOP definition. The investigators consecutively admitted patients the questionnaire and evaluated the assessment of muscle strength (grip strength test and chair stand test), muscle quantity (L3 plane total skeletal muscle area) and physical performance (gait test) following the F-A-C-S approach, to confirm patients with sarcopenia accurately. And by tracking the short-term and long-term outcomes of patients after hepatectomy, the differences were analyzed and the relationship between sarcopenia and liver cancer was explored.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTgait speed; ct scan;grip strength and chair stand testThe chair stand test was administered, and the time required for the patient to stand five times from a sitting position without using the arms was measured. CT scan was to scan the patient's third lumbar level. For the gait speed test, the time that patients spent walking 8 meters on a flat indoor floor at usual walking speed was measured.Grip strength test:the dominant hand and the nondominant hand were measured twice intermittently (kg), and the average value of 4 values was obtained.

Timeline

Start date
2020-05-01
Primary completion
2021-08-11
Completion
2025-08-28
First posted
2022-04-21
Last updated
2022-06-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05339919. Inclusion in this directory is not an endorsement.